GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) (NO.1) LIMITED

Company number 00753340

Date	Type	Description	View / Download
17 Mar 2020	TM01	Termination of appointment of Richard Green as a director on 10 March 2020	(1 page)
20 Feb 2020	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/19	(3 pages)
20 Feb 2020	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/19	(1 page)
27 Jan 2020	CS01	Confirmation statement made on 27 January 2020 with updates	(4 pages)
17 Dec 2019	PSC02	Notification of Prism Pch Limited as a person with significant control on 13 December 2019	(2 pages)
17 Dec 2019	PSC07	Cessation of Consumer Healthcare Holdings Limited as a person with significant control on 13 December 2019	(1 page)
03 Dec 2019	AP01	Appointment of Mr Nicholas Ian Cooper as a director on 11 September 2019	(2 pages)
11 Sep 2019	PSC02	Notification of Consumer Healthcare Holdings Limited as a person with significant control on 2 July 2019	(2 pages)
11 Sep 2019	PSC07	Cessation of Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 2 July 2019	(1 page)
30 Aug 2019	AP01	Appointment of Mr Antrinkos Andrew Aristidou as a director on 19 August 2019	(2 pages)
22 Aug 2019	AA	Full accounts made up to 31 December 2018	(19 pages)
04 Apr 2019	CS01	Confirmation statement made on 29 March 2019 with no updates	(3 pages)
24 Jan 2019	AP01	Appointment of Mr Richard Green as a director on 15 January 2019	(2 pages)
22 Jan 2019	TM01	Termination of appointment of Melanie Foster-Hawes as a director on 15 January 2019	(1 page)
01 Jun 2018	AD01	Registered office address changed from Park View Riverside Way Watchmoor Park Camberley Surrey GU15 3YL to 980 Great West Road Brentford Middlesex TW8 9GS on 1 June 2018	(1 page)
01 Jun 2018	RESOLUTIONS	Resolutions NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2018-05-25	(3 pages)
11 Apr 2018	CS01	Confirmation statement made on 29 March 2018 with updates	(3 pages)
04 Apr 2018	AA	Full accounts made up to 31 December 2017	(22 pages)
18 Dec 2017	AP01	Appointment of Terence O'neill as a director on 30 November 2017	(3 pages)
14 Dec 2017	AP02	Appointment of Glaxo Group Limited as a director on 30 November 2017	(2 pages)
12 Dec 2017	AP02	Appointment of The Wellcome Foundation Limited as a director on 30 November 2017	(2 pages)
12 Dec 2017	TM01	Termination of appointment of Jonathan Wilson Box as a director on 30 November 2017	(1 page)
08 Jun 2017	AA	Full accounts made up to 31 December 2016	(26 pages)
07 Apr 2017	CS01	Confirmation statement made on 29 March 2017 with updates	(5 pages)
02 Nov 2016	SH01	Statement of capital following an allotment of shares on 1 November 2016 GBP 26,100	(3 pages)